Publications

5808 Results

Elevated MIG, IL-2R and IL1-R1 are associated with early progression in in Follicular Lymphoma

Authors
M Mir;M Maurer;SC Ziesmer;S Slager;T Habermann;BK Link;T Witzig;J Friedberg;O Press;M Leblanc;JR Cerhan;A Novak;S Ansell
Journal / Conference
ASH Lymphoma Biology Conference (August 10-13, Colorado Springs, CO), poster presentation;
Year
2014
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Vitamin B12 (Vit B12) biochemical (BCH) deficiency (DEF) in non-diabetic breast cancer (BC) patients on NCIC CTG MA.32: A phase III randomized adjuvant BC trial comparing metformin (Met) to placebo (Pl)

Authors
MF Liebman;W Brien;W Parulekar;K Gelmon;L Shepherd;J Ligibel;D Hershman;P Rastogi;IA Mayer;TJ Hobday;J Lemieux;AM Thompson;KI Pritchard;TJ Whelan;S Mukherjee;HI Chalchal;V Bernstein;V Stambolic;BE Chen;PJ Goodwin
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 542); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
Year
2014
Research Committee(s)
Breast

Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG

Authors
JC Buckner;SL Pugh;EG Shaw;MR Gilbert;G Barger;S Coons;P Ricci;D Bullard;PD Brown;K Stelzer;D Brachman;JH Suh;CJ Schultz;J-P Bahary;BJ Fisher;H Kim;AD Murtha;WJ Curran;MP Mehta
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 2000); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), oral session;
Year
2014
Research Committee(s)
Brain
Study Number(s)
R9802

The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials

Authors
S Halabi;WK Kelly;H Zhou;AJ Armstrong;D Quinn;K Fizazi;NC Solomon;I Tannock;D Petrylak;MJ Morris;E Small
Journal / Conference
Journal of Clinical Oncology 32:5s (suppl; abstr 5002); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), oral session;
Year
2014
Research Committee(s)
Genitourinary
Study Number(s)
S0421, S9916

Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)

Authors
M Fuchs;K Sato;D Niedzwiecki;X Ye;LB Saltz;RJ Meyer;RB Mowat;R Whittom;A Hantel;A Benson;D Atienza;M Messino;H Kindler;A Venook;S Ogino;K Wu;WC Willett;EL Giovannucci;JA Meyerhardt
Journal / Conference
PLOS ONE 9(6):e99816;
Year
2014
Research Committee(s)
Gastrointestinal
PMID
PMID24512953
PMC
PMC4019685
Study Number(s)
C89803

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH

Authors
JG Cairncross;RB Jenkins;EG Shaw;C Giannini;DG Brachman;JC Buckner;KL Fink;L Souhami;NJ Laperriere;JT Huse;MP Mehta;WJ Curran
Journal / Conference
Journal of Clinical Oncology 32(8):783-790
Year
2014
Research Committee(s)
Brain
PMID
PMID24516018
PMC
PMC3940537

Functional partitioning of prostate cancer heritability in Europeans and African Americans from AAPC and BPC3 consortia reveals cell-type specificity

Authors
A Gusev;SS Strom;RA Kittles;BA Rybicki;JL Stanford;P Goodman;S Berndt;LB Signorello;J Carpten;G Casey;L Chu;DV Conti;KA Rand;Y Han;V Stephens;JM Ansell Hennis;EM John;EA Klein;S Kolb;L LeMarchand;SC Leske;AB Murphy;C Neslund-Dudas;C Pettaway;SM Gapstur;SL Zheng;S-Y Wu;JS Witte;J Xu;W Isaacs;SA Ingles;FR Schumacher;S Chanock;B Nemesure;WJ Blot;DO Stram;BE Henderson;AL Price;M Freedman;CA Haiman;B Pasaniuc
Journal / Conference
American Society of Human Genetics Annual Meeting (October 18-22, 2014, San Diego, CA), platform (oral) presentation;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates with neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev) in triple-negative breast cancer (TNBC):correlative studies from CALGB 40603/CALGB 150709 (Alliance).

Authors
W Sikov;W Barry;A Hoadley;BN Pitcher;B Singh;S Tolaney;C Kuzma;T Pluard;G Somlo;E Port;M Golshan;DA Berry;O Hahn;L Carey;C Perou;C Hudis;E Winer
Journal / Conference
San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abstr. [S4-05], oral presentation;
Year
2014
Research Committee(s)
Breast
Study Number(s)
CTSU/C40603

Adjuvant exemestane with ovarian suppression in pre-menopausal breast cancer

Authors
O Pagani;MM Regan;B Walley;G Fleming;M Colleoni;I Lang;H Gomez;C Tondini;H Burstein;EA Perez;E Ciruelos;V Stearns;H Bonnefoi;S Martino;M Rabaglio;AS Coates;RD Gelber;A Goldhirsch;P Francis
Journal / Conference
New England Journal of Medicine 371(2):107-118;
Year
2014
Research Committee(s)
Breast and Cancer Survivorship
PMID
PMID24881463
PMC
PMC4175521

Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer

Authors
KA Hoadley;WT Barry;B Pitcher;J Parker;M Wilkerson;N Henry;I Krop;DA Berry;ER Mardis;CM Perou;E Winer;CA Hudis;LA Carey
Journal / Conference
San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX), abst. [S3-06], oral;
Year
2014
Research Committee(s)
Breast